In this work, we observed that the overall survival outcome was significantly associated with a high level of PDGFA and a low level of KLK6 and KLK10 expression in melanoma tumors and that these genes were expressed in an opposite way in XP patients who developed melanoma at a young age. The gene discussed is KLK10; the disease is melanoma.